← Eichor
Study identifier: NCT06918392 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Field-test and Psychometric Validation of the Pectus Excavatum Evaluation Questionnaire in the Dutch Pectus Excavatum Population

Condition: Pectus Excavatum  ·  Sponsor: Erik de Loos

PhaseN/A
Planned participants66
Who can joinAll sexes, 12 Years to 18 Years
Healthy volunteersNo

About this study

A questionnaire that can measure disease severity from the patients perspective in patients with pectus excavatum already exists in English (Pectus Excavatum Evaluation Questionnaire; PEEQ). This questionnaire was recently translated into Dutch. Before this Dutch version can be used, it needs to be tested by a number of patients. Data will be collected at three moments: 1. Preoperatively: The PEEQ will be completed on paper during the outpatient clinic visit. 2. Postoperatively: The PEEQ will be completed electronically 2 months post-surgery. 3. Test-retest reliability: The PEEQ will be administered electronically at least two weeks after a previous assessment.

This description comes directly from the study's public registry record.

Talk to the study team

Erik R de Loos, MD, PhD  ·  +3188 459 9719  ·  e.deloos@zuyderland.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Zuyderland Medical CenterHeerlen, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06918392